- Home
- HOLX vs BMRN Comparison
HOLX vs BMRN Comparison
Compare HOLX & BMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HOLX
- BMRN
- Stock Information
- Founded
- HOLX 1985
- BMRN 1996
- Country
- HOLX United States
- BMRN United States
- Employees
- HOLX N/A
- BMRN N/A
- Industry
- HOLX Medical Electronics
- BMRN Biotechnology: Pharmaceutical Preparations
- Sector
- HOLX Health Care
- BMRN Health Care
- Exchange
- HOLX Nasdaq
- BMRN Nasdaq
- Market Cap
- HOLX 16.3B
- BMRN 13.7B
- IPO Year
- HOLX 1990
- BMRN 1999
- Fundamental
- Price
- HOLX $57.56
- BMRN $59.17
- Analyst Decision
- HOLX Buy
- BMRN Buy
- Analyst Count
- HOLX 14
- BMRN 22
- Target Price
- HOLX $84.17
- BMRN $94.00
- AVG Volume (30 Days)
- HOLX 3.7M
- BMRN 2.0M
- Earning Date
- HOLX 05-01-2025
- BMRN 05-01-2025
- Dividend Yield
- HOLX N/A
- BMRN N/A
- EPS Growth
- HOLX 50.83
- BMRN 153.71
- EPS
- HOLX 3.16
- BMRN 2.21
- Revenue
- HOLX $4,039,000,000.00
- BMRN $2,853,915,000.00
- Revenue This Year
- HOLX $3.37
- BMRN $12.23
- Revenue Next Year
- HOLX $5.40
- BMRN $9.93
- P/E Ratio
- HOLX $18.24
- BMRN $26.81
- Revenue Growth
- HOLX 1.76
- BMRN 17.97
- 52 Week Low
- HOLX $56.27
- BMRN $52.93
- 52 Week High
- HOLX $84.67
- BMRN $94.85
- Technical
- Relative Strength Index (RSI)
- HOLX 39.33
- BMRN 37.64
- Support Level
- HOLX $56.27
- BMRN $52.93
- Resistance Level
- HOLX $59.02
- BMRN $60.93
- Average True Range (ATR)
- HOLX 2.18
- BMRN 3.18
- MACD
- HOLX -0.19
- BMRN -0.53
- Stochastic Oscillator
- HOLX 23.49
- BMRN 34.01
About HOLX Hologic Inc.
Hologic manufactures proprietary products for the healthcare needs of women. The company operates in five segments: diagnostics (44% of total sales), breast health (38%), surgical (16%), and skeletal health (2%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (69%), followed by Europe (20%), Asia (8%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts.
About BMRN BioMarin Pharmaceutical Inc.
BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments aimed at addressing complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria (PKU), hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development.